Syntax Bio Appoints Ryan Clarke as Chief Scientific Officer and Nikolas Balanis as Chief Technology Officer
Position
Chief Technology Officer
Company
Syntax Bio
ChicagoBiotechnologyHealth CareTherapeuticsDescription
Syntax Bio has announced key leadership appointments within its executive team. Co-founder Ryan Clarke transitions to Chief Scientific Officer, while Nikolas Balanis has been elevated to Chief Technology Officer.
Quick answer
Syntax Bio Appoints Ryan Clarke as Chief Scientific Officer and Nikolas Balanis as Chief Technology Officer (June 21, 2026). Syntax Bio is based in Chicago, Illinois, United States.
- Who is the new Chief Technology Officer at Syntax Bio?
- Syntax Bio named Nikolas Balanis Chief Technology Officer, announced June 21, 2026.
- What did Syntax Bio announce on June 21, 2026?
- Syntax Bio has announced key leadership appointments within its executive team. Co-founder Ryan Clarke transitions to Chief Scientific Officer, while Nikolas Balanis has been elevated to Chief Technology Officer.
- What does Syntax Bio do?
- Syntax Bio is a synthetic biology company that specializes in next-generation cell therapies.
- Where is Syntax Bio based?
- Syntax Bio is based in Chicago, Illinois, United States.
- Which similar companies made leadership changes around the same time?
- First Ascent Biomedical (June 22, 2026), Arvinas (June 22, 2026), Veristat (June 23, 2026) and Insmed Incorporated (June 23, 2026) also announced leadership changes within 45 days of Syntax Bio.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- First Ascent Biomedical Appoints Raymond Rodriguez-Torres as President (June 22, 2026)
- Arvinas, Inc. Begins Search for New Chief Medical Officer (June 22, 2026)
- Veristat Appoints Clint Wolfe as Chief Human Resources Officer (June 23, 2026)
- Insmed Incorporates Samuele Butera as Senior Vice President, General Manager (June 23, 2026)
- Acurion Appoints Mike Hoerres as Chief Commercial Officer and David Schlessinger as Vice President of Product Development (June 17, 2026)
- Bristol Myers Squibb Appoints Mayada Al-Ahmad as General Manager of Saudi Arabia and Gulf Countries (June 17, 2026)
Who to call at Syntax Bio, and when
A new leader at Syntax Bio brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Syntax Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Syntax Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Syntax Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Syntax Bio changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Syntax Bio changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.